Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital

Towards selective CNS PET imaging of the 5-HT7 receptor system: Past, present and future

Publikation: Bidrag til tidsskriftReviewForskningpeer review

  1. Systemic DNA and RNA damage from oxidation after serotonergic treatment of unipolar depression

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. PET-BIDS, an extension to the brain imaging data structure for positron emission tomography

    Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

Vis graf over relationer

Since its discovery in 1993, the serotonin receptor subtype 7 (5-HT7) has attracted significant attention as a potential drug target; due to its elucidated roles in conditions such as insomnia, schizophrenia, and more. Therefore, it is unsurprising that there has been relatively early efforts undertaken to develop a positron emission tomography (PET) imaging agent for said receptor system. PET can be clinically used to probe receptor systems in vivo, permitting information such as a drug's occupancy against this system to be investigated. This review focuses on the efforts towards the development of a 5-HT7R selective PET CNS tracer over the last 20 years, critically reflecting on applied strategies and commonly employed chemical frameworks and suggests future considerations that are needed to successfully develop a PET tracer for this clinically relevant target. This article is part of the special issue entitled 'Serotonin Research: Crossing Scales and Boundaries'.

Sider (fra-til)107830
StatusUdgivet - 1 aug. 2020

Bibliografisk note

Copyright © 2019. Published by Elsevier Ltd.

ID: 60966720